ANDREA CLEVELAND: Open Payments
NPI 1790433894 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 13 payments from 9 companies in 2025. Trend: 2023 $226 · 2024 $178 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $182 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $125 |
| 180 Medical, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Lilly USA, LLC | 1 | $23 |
| Amgen Inc. | 1 | $20 |
| Organon LLC | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: BOTOX, ILUMYA, SKYRIZI, COSENTYX, EBGLYSS, OTEZLA, TREMFYA.
Industry payments across OH — which companies pay providers there.
